Pharma Profits > Human Lives
Novo Nordisk made $17.6 billion last year—on a drug that costs them $5 to make.

Insulin, a 100-year-old medication, is priced at $300+ per vial in the U.S. because they can.

Meanwhile, diabetics ration their doses and die. That’s not a business model—it’s extortion.